Compile Data Set for Download or QSAR
maximum 50k data
Found 12 Enz. Inhib. hit(s) with all data for entry = 10336
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM651387((E)-2-(5-((4-(2-hydroxyethyl)piperidin-1-yl)sulfon...)
Affinity DataIC50:  0.160nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536301((E)-2-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfony...)
Affinity DataIC50:  0.25nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536314((E)-2-(2-ethoxy-5-((4-(3-hydroxypropyl)piperazin-1...)
Affinity DataIC50:  0.420nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM651390((E)-2-(2-ethoxy-5-((4-(2-hydroxyethyl)piperidin-1l...)
Affinity DataIC50:  0.480nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536303((E)-5-methyl-2-(5-((4-methylpiperazin-1-yl)sulfony...)
Affinity DataIC50:  0.530nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536306(3-(2-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl...)
Affinity DataIC50:  1.5nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536316(2-(2-ethoxy-5-((4-(3-hydroxypropyl)piperazin-1-yl)...)
Affinity DataIC50:  2.80nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536307(2-(2-ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)s...)
Affinity DataIC50:  4.10nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM14390(5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phen...)
Affinity DataIC50:  5.40nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536302(2-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)ph...)
Affinity DataIC50:  12nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM536315((E)-3-(4-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50:  12nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Topadur Pharma

US Patent
LigandPNGBDBM651391((E)-2-(1-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50:  66nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent